| Code | 52130 | ||||||||||
| MA number | 61/0042/04-S | ||||||||||
| Product Form: | sol por 20x15 ml (vre.PET/Al/PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Fresenius Kabi Austria GmbH, Austria | ||||||||||
| Therapeutic Class: | 61 - LAXANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 02.03.2004 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_LAEVOLAC_sol por_05_2022.pdf
|
| SPC: |
SPC_LAEVOLAC_sol por_05_2022.pdf
|
| Safety feature | Yes |
| Data update: | 01.04.2019 |
